Board & Key Stakeholders

HQIP Board of Directors:

• Janet Davies (Chair)
• Jeremy Taylor (Vice Chair)
• Professor Sir Sabaratnam Arulkumaran
• Tina Donnelly
• Richard Driscoll
• Tim Golbourn
• Anne Keatley-Clarke
• Dr Imran Rafi
• Dr Kevin Stewart

Minutes of Board meetings >>

Key stakeholders:

HQIP's key stakeholders are of course the various funding bodies which support our work, including the Department of Health in England, the Welsh Assembly Government and others. Other key stakeholder include the very many professional and patient bodies with whom we work closely, and more generally, users of health and social care services as  whole.

HQIP has two advisory groups, one of patients, and one of people working in quality improvement (UKQC). We are currently setting up a further, much larger advisory group which will offer opportunity for a wider group of stakeholders to be actively involved in shaping our practice. This should be appointed from April 2012.

The Department of Health and the Welsh Assembly Government both have advisory groups that shape work on audit as a whole through offering these Government's advice, and which assist us with ensuring the probity of the commissioning process. In England this group is called NAGCAE.

Department of Health announcement on name change from NCAAG to NAGCAE, made 17 January 2012

As of 1 January 2012 NCAAG has been renamed the National Advisory Group on Clinical Audit & Enquiries (NAGCAE).

A change of name from NCAAG was required for two reasons:

• to correct the widespread misunderstanding engendered by the previous title that the group's remit is restricted to National Clinical Audit rather than embracing clinical audit in general; and,

• to reflect the added responsibility to provide policy and strategic advice to the Department of Health as regards national confidential enquiries into the safety of care funded by the Clinical Outcome Review Programme.

Terms of reference: NAGCAE's responsibilities are:

• to provide policy and strategic advice to the Department of Health on clinical audit, national confidential enquiries and other issues as requested;

• to support the reinvigoration of clinical audit, both nationally and locally, so as to stimulate improvements in clinical practice and service delivery;

• to provide advice and guidance to the Department of Health on the National Clinical Audit & Patient Outcomes Programme (NCAPOP) including advising on topics for new national clinical audits, on topics to be discontinued and on the selection of tenders for supplying national clinical audits; and

• to provide advice and guidance to the Department of Health on the Clinical Outcome Review Programme (CORP) including advising on clinical areas for national enquiries, on areas to be discontinued and on the selection of tenders for supplying national clinical enquiries. (Note: this does not include responsibility for advising on specific topics within a clinical area).

Contact NAGCAE: nagcae@hqip.org.uk